The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Differential effects of MDMA and methylphenidate on social cognition
Open accessAbstract
Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown. We investigated the acute effects of MDMA (75 mg), methylphenidate (40 mg) and placebo using the Facial Emotion Recognition Task, Multifaceted Empathy Test, Movie for the Assessment of Social Cognition, Social Value Orientation Test and the Moral Judgment Task in a cross-over study in 30 healthy subjects. Additionally, subjective, autonomic, pharmacokinetic, endocrine and adverse drug effects were measured. MDMA enhanced emotional empathy for positive emotionally charged situations in the MET and tended to reduce the recognition of sad faces in the Facial Emotion Recognition Task. MDMA had no effects on cognitive empathy in the Multifaceted Empathy Test or social cognitive inferences in the Movie for the Assessment of Social Cognition. MDMA produced subjective 'empathogenic' effects, such as drug liking, closeness to others, openness and trust. In contrast, methylphenidate lacked such subjective effects and did not alter emotional processing, empathy or mental perspective-taking. MDMA but not methylphenidate increased the plasma levels of oxytocin and prolactin. None of the drugs influenced moral judgment. Effects on emotion recognition and emotional empathy were evident at a low dose of MDMA and likely contribute to the popularity of the drug.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By decreasing reactivity to perceived criticism and enhancing emotional empathy (152), MDMA may help narcissistic patients tolerate vulnerability and interpersonal closeness without triggering defensiveness.”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [152]
In the citing paper
“It enhances affective empathy for positive emotions while impairing recognition of negative emotions, such as sadness or fear, which could potentially help narcissistic individuals tolerate and engage with emotions they would otherwise suppress (152).”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [152]
In the citing paper
“In two studies this increase was particularly pronounced in response to positive stimuli and in male participants (10, 51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“One hundred twenty-five milligrams as well as 75 mg MDMA increased emotional empathy (10, 51, 52).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“In line with this, MDMA (75, 100, & 125 mg), GHB (20 mg/kg), and psilocybin (0.215 mg/kg) did not affect cognitive empathy on the MET (10, 12, 51–53, 62).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Using moral dilemma tasks, it has been shown that neither MDMA (75 mg) nor psilocybin (0.215 mg/kg) influenced moral decision making (12, 51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“While MDMA did not change behavior on the SVO when administered in a lower dose (75 mg) (51)”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“For example, increases in emotional empathy, impaired identification of negative emotions, enhanced decoding of positive facial expressions, and increased altruistic choices after MDMA administration were not related to oxytocin plasma levels or other neuroendocrine effects (10, 51, 52, 54).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Interestingly, these social functions were not influenced by acute administration of MDMA in controlled studies (10, 51, 52).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Decreased recognition of negative emotions induced by psilocybin on the RMET was blocked by pretreatment with the 5-HT2A receptor antagonist ketanserin (51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“Furthermore, methylphenidate lacked the empathy enhancing properties of MDMA (51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
In the citing paper
“LSD and MDMA have shown some dose-dependent effects on empathy and altruistic behavior (10, 33, 51), indicating that robust modulations are measurable at doses of 100 mg MDMA/100µg LSD and above.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [51]
Citations
Cites
Measuring Social Value OrientationPreprint
Murphy, R. O., Ackermann, K., & Handgraaf, M. (2011) · Social Science Research Network · doi:10.2139/ssrn.1804189 · Cited by 1,099
Dziobek, I., Rogers, K., Fleck, S., Bahnemann, M., Heekeren, H. R., Wolf, O. T., & Convit, A. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0486-x · Cited by 951
Measuring Social Value Orientation
Murphy, R. O., Ackermann, K. A., & Handgraaf, M. J. J. (2011) · Judgment and Decision Making · doi:10.1017/s1930297500004204 · Cited by 948
Introducing MASC: A Movie for the Assessment of Social Cognition
Dziobek, I., Fleck, S., Kalbe, E., Rogers, K., Hassenstab, J., Brand, M., Kessler, J., Woike, J. K., Wolf, O. T., & Convit, A. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0107-0 · Cited by 926
McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2004) · Addiction · doi:10.1111/j.1360-0443.2005.00944.x · Cited by 880
Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans
Hurlemann, R., Patin, A., Onur, O. A., Cohen, M. X., Baumgartner, T., Metzler, S., Dziobek, I., Gallinat, J., Wagner, M., Maier, W., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5538-09.2010 · Cited by 771
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674
Harmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1256 · Cited by 554
Serotonin selectively influences moral judgment and behavior through effects on harm aversion
Crockett, M. J., Clark, L., Hauser, M. D., & Robbins, T. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009396107 · Cited by 526
Self-citation
Research works printed but not linked: 3
- Hysek CM, 2013, Soc Cogn Affect Neurosci
- Janke W, 1978, Die Eigenschaftswörterliste
- Zerssen DV, 1976, Die Beschwerden-Liste. Münchener Informationssystem
Cited by
Sorted by citations
Items 101–155 of 155
Psychoactive substances for the treatment of neuropsychiatric disorders
Zhen, Z., Sun, X., Yuan, S., & Zhang, J. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104193 · Cited by 11
Healy, C. J., Frazier, A., Kirsch, S., Sanford, A., Garcia‐Romeu, A., Todman, M., Varon, J. P., & D'Andrea, W. M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111361 · Cited by 9
Psychedelic medicine: mechanisms, evidence, and translation to practice
Jacobs, E., Zahid, Z., Hinkle, J. T., Nayak, S. M., & Yaden, D. B. (2026) · BMJ · doi:10.1136/bmj-2024-081723 · Cited by 9
Methylphenidate and emotional-motivational processing in attention-deficit/hyperactivity disorder
Conzelmann, A., Woidich, E., Mucha, R. F., Weyers, P., Müller, M., Lesch, K., Jacob, C., & Pauli, P. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1512-y · Cited by 10
MDMA enhances positive affective responses to social feedback
Bershad, A. K., Hsu, D. T., & de Wit, H. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811231224153 · Cited by 9
Mentalising and depression: a mini-review on behavior, neural substrates, and treatment options
Langenbach, B. P., Koelkebeck, K., & Knoch, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1116306 · Cited by 9
Zoratto, F., Franchi, F., Macrı̀, S., & Giovanni Laviola, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05229-9 · Cited by 8
A Systematic Review of the MDMA Model to Address Social Impairment in Autism
Chaliha, D. R., Mamo, J. C. L., Albrecht, M. A., Lam, V., Takechi, R., & Vaccarezza, M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210101130258 · Cited by 7
Pharmacoterrorism: the potential role of psychoactive drugs in the Paris and Tunisian attacks
Fond, G. B., & Howes, O. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4204-2 · Cited by 7
Albert, A. E., & Back, A. L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1529427 · Cited by 6
Angerer, V., Schmid, Y., Franz, F., Gnann, H., Speer, J. M., Gnann, A., Helmecke, S., Buchwald, A., Brandt, S. D., Passie, T., et al. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3622 · Cited by 8
Self-citationGaddis, A., Lake, S., Tupper, K. W., Nosova, E., Blommaert, K., Wood, E., & DeBeck, K. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.035 · Cited by 6
Dolder, P. C., Perna, E. B. D. S. F., Mason, N. L., Hutten, N. R. P. W., Toennes, S. W., Theunissen, E. L., Ramaekers, J. G., & Kuypers, K. P. C. (2018) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2680 · Cited by 7
Kupferberg, A., & Hasler, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1372650 · Cited by 5
Treatment of neuropathic pain with repeated low-dose MDMA: a case report
Gasser, P., Liechti, M. E., & Holze, F. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1513022 · Cited by 6
Self-citationPharmacies as potential providers of harm reduction services: A preliminary online survey
James, E., Robertshaw, T. L., Westwell, A. D., & Smith, A. P. (2018) · Drug Science Policy and Law · doi:10.1177/2050324518767441 · Cited by 4
MDMA – hopes and fears associated with therapeutic use in mental disorders
Kozera, K., Cichoń, L., Wilczyński, K. M., & Janas-Kozik, M. H. (2020) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2020.10.002 · Cited by 4
Ramaekers, J. G., Kuypers, K. P. C., & Vollenweider, F. X. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03602-7 · Cited by 3
Dessoki, H. H., Amin, O. R., Soltan, M. R., Abbas, M. M., & Dawoud, M. E. (2020) · Middle East Current Psychiatry · doi:10.1186/s43045-020-00020-5 · Cited by 3
Bershad, A. K., & de Wit, H. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.09.006 · Cited by 3
Anxiety-related Symptoms following the Sporadic Use of Ecstasy – A Case Study
Majić, T., Brandt, L., & Montag, C. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2021.2006372 · Cited by 3
Tang, B. L. (2025) · Psychoactives · doi:10.3390/psychoactives4010005 · Cited by 3
Neurotransmitter modulation of human facial emotion recognition
Vlazaki, M., Harmer, C. J., Cowen, P. J., & Pulcu, E. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251338225 · Cited by 4
Acute and Long-Term Effects of Ayahuasca on (Higher-Order) Cognitive Processes
Mason, N. L., & Kuypers, K. P. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_7 · Cited by 3
Animal Behavior: Socializing Octopus
Gutnick, T., & Kuba, M. J. (2018) · Current Biology · doi:10.1016/j.cub.2018.08.006 · Cited by 3
Glowacki, D. R., Williams, R. R., Maynard, O., Pike, J. E., Freire, R., Wonnacott, M., & Chatziapostolou, M. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2105.07796 · Cited by 3
Psychedelics and cognitive function: A systematic review
Cardoso, C. G., & Viana, M. D. B. (2023) · Research Society and Development · doi:10.33448/rsd-v12i14.44436 · Cited by 2
Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study
Dellanoce, F. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1617428 · Cited by 2
LSD acutely impairs fear recognition and enhances emotional empathy and sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(16)31139-7 · Cited by 4
Self-citationJones, G. M., Lipson, J., & Wang, E. (2023) · Scientific Reports · doi:10.1038/s41598-023-29763-x · Cited by 3
Eaton, E. M., Capone, C., Gully, B. J., Brown, Z. E., Monnig, M. A., Worden, M. S., Swift, R. M., & Haass‐Koffler, C. L. (2024) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2024.101333 · Cited by 4
MDMA for treatment of PTSD and neurorehabilitation in military populations
Dunn, W., Bershad, A. K., Krantz, D. E., & Vermetten, E. H. G. J. M. (2024) · Neurorehabilitation · doi:10.3233/nre-230270 · Cited by 2
Tani, N., Ikeda, T., Aoki, Y., Shida, A., Oritani, S., & Ishikawa, T. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119864139 · Cited by 2
Biochemical contributions to interpersonal emotion dynamics
Way, B. M., & Keaveney, A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316822944.007 · Cited by 2
Update of the Altered States Database (ASDB): 2022-12-31Preprint
Peters, M., Prugger, J., Dimkov, P. R., & Schmidt, T. T. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/wdfhg · Cited by 3
MDMA as well as amphetamine and alcohol increase feelings of social closeness in healthy adults
de Wit, H., Hahn, E., Smadi, S., Li, T., & Molla, H. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-82632-z · Cited by 2
Martinez, R. L., Radošić, N., Molla, H. M., de Wit, H., & Lyubomirsky, S. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251370999 · Cited by 1
A meta-analytic analysis of the acute effects of MDMA on empathy and emotion recognition in humans
Peled‐Avron, L., Aday, J. S., Pantoni, M. M., Hamilton, H., & Woolley, J. D. (2025) · Scientific Reports · doi:10.1038/s41598-025-25610-3 · Cited by 1
Thomas, J. E., Dellarole, A., & Caballero, J. (2026) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxag062 · Cited by 2
Belinger, L., Rieser, N. M., Engeli, E., Becciolini, L., Clamote, M., Pribiš, M., Saissi, F., Florineth, G. A., Hehl, N. L., Herdener, M., et al. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112879 · Cited by 1
Edsinger, E., & Dölen, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/301192 · Cited by 1
Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa
Lutyens, D. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.21904854 · Cited by 2
Krüeger, F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108770880.017
Lee, M. R., Veerareddy, A., & Krüeger, F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108770880.019
The good, the bad, and the intoxicated
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm
MDMA enhances early visual processing for salient socio-emotional stimuli.Preprint
Haggarty, C. J., Bershad, A. K., Kumar, M., Lee, R., & de Wit, H. (2024) · doi:10.22541/au.171117634.48543663/v1
Psychedelic Drugs as Treatment Agents
Yehuda, R., Lepow, L., Bonnano, P. A., Zaretsky, T. G., Antonio, J. H., & Jagodnik, K. M. (2025) · doi:10.1093/med/9780197640654.003.0074
Tang, B. L. (2025) · Psychoactives · doi:10.3390/psychoactives4040044
Choreographing time: toward therapy-aligned entactogens for complex PTSD
Parikh, A. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-025-02314-w
Tully, J., & Hind, E. (2026) · Aggression and Violent Behavior · doi:10.1016/j.avb.2026.102144
INTERVENTIONS AND TREATMENT FOR THE EFFECTS OF ACEs
Riley, D., & Pates, R. M. (2026) · doi:10.1002/9781394282432.ch13
Shared effects of the opioid antagonist naltrexone on first-hand and empathic pain
Braunstein, J., Rütgen, M., & Lamm, C. (2026) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsag018
Stocker, K., Hartmann, M., Barrett, F. S., Richards, W. A., Sepeda, N. D., Ley, L., Becker, A. M., Holze, F., & Liechti, M. E. (2026) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.70073
Self-citationMason, N. L., Mallaroni, P., Kuypers, K. P. C., de la Torre, R., Reckweg, J. T., Preller, K. H., & Ramaekers, J. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742704
Theory of Mind in Psychoactive Substance Users: A Systematic Literature Review and Meta-analysis
Neto, J. V. D. L., & Osório, F. D. L. (2026) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-026-01717-0
Metadata
- Authors
- Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E.
- Affiliations
- University Hospital of Basel (CH)
- Wellcome Centre for Human Neuroimaging (GB)
- University Hospital Zurich (CH)
- Corresponding author
- Liechti, Matthias E
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-07-22
- Volume
- 28
- Issue
- 9
- Pages
- 847-856
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2073612520
- Cited by
- 155
- References
- 37
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 16 · 2023: 14 · 2022: 7 · 2021: 12 · 2020: 10 · 2019: 10 · 2018: 18 · 2017: 16 · 2016: 14 · 2015: 12 · 2014: 4
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- green
- edoc.unibas.ch
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- edoc (University of Basel)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- MDMA, ecstasy, methylphenidate, social cognition, affective empathy, cognitive empathy, facial emotion recognition, social value orientation, moral judgment, oxytocin, prolactin, subjective effects, acute drug effects, cognitive enhancement
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Cognition, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Empathy, Epinephrine, Facial Expression, Female, Hallucinogens, Humans, Hydrocortisone, Judgment, Male, Methylphenidate, Oxytocin, Prolactin, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Recognition, Psychology, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
